GlassScriptPhysician profile
Sung Bae Lee
NPI 1740260231
$1,206.01
in general payments reported to CMS, 2019-2025
19 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $49.19 · 2021: $92.06 · 2022: $329 · 2023: $239 · 2024: $100 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microtransponder, INC. | $217.69 | 2025 | |
| Medtronic, INC. | $173.85 | 2021-2023 | Solitaire X |
| Microvention, INC. | $165.81 | 2022-2024 | Balloon Catheter |
| Novo Nordisk INC | $103.71 | 2022 | |
| Medtronic Vascular, INC. | $88.61 | 2019 | |
| Silk Road Medical, INC. | $80.83 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic USA, INC. | $49.19 | 2020 | |
| Inspiremd LTD | $45.37 | 2025 | Cguard Prime Carotid Stent System |
| Ucb, INC. | $41.58 | 2021 | |
| Siemens Medical Solutions USA, INC. | $35.56 | 2022-2023 | Multitom Rax, Artis Icono Floor, Naeotom Alpha |
| Cardiva Medical, INC. | $33.60 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Cordis US Corp. | $27.67 | 2022-2023 | Radial 360 |
| Terumo Medical Corporation | $24.44 | 2019 | |
| Eisai INC. | $23.81 | 2022 | |
| Avanos Medical | $23.45 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $20.41 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $19.59 | 2023 | Dysport |
| Abbott Laboratories | $15.91 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sung Bae Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.